Alfacalcidol (Standard)
Alfacalcidol (Standard) is the analytical standard of Alfacalcidol. This product is intended for research and analytical applications. Alfacalcidol (1-hydroxycholecalciferol) is a vitamin D active metabolites, acts as a non-selective VDR activator medication, and widely be used in the management of osteoporosis.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté : 98%
- CAS No.: 41294-56-8
- Formule: C27H44O2
- Masse moléculaire:400.64
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Pureté et documentation
-
Help & FAQs
-
HY-10003
AlfacalcidolVDR Activator -
HY-10002
CalcitriolVDR Agonist -
HY-32351
CalcifediolVDR Ligand -
HY-32348
DoxercalciferolVD/VDR Activator -
HY-10002R
Calcitriol (Standard)VDR Agonist -
HY-15398
Vitamin D3Vitamin -
HY-10001
CalcipotriolVitamin D3 Analog -
HY-76542
Vitamin D2Vitamin D Supplement -
HY-50919
ParicalcitolVitamin D Receptor Agonist -
HY-14649
Retinoic acidRAR Agonist -
HY-B0166
L-Ascorbic acidAntioxidant -
HY-B0511
BiotinVitamin B7
Product Information
Information
Application
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS No. 41294-56-8
-
Masse moléculaire 400.64
-
Formule C27H44O2
-
SMILES
C=C1[C@H](C[C@@H](C/C1=C/C=C2[C@]3([C@@](C)([C@H](CC3)[C@@H](CCCC(C)C)C)CCC/2)[H])O)O
-
Synonyms
1-hydroxycholecalciferol (Standard); 1.alpha.-Hydroxyvitamin D3 (Standard)
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Galeşanu C, et al. [Postmenopausal osteoporosis. Digital Rx radiogrammetry in the diagnosis and follow-up of treatment with alfacalcidol]. Rev Med Chir Soc Med Nat Iasi. 2006 Oct-Dec;110(4):833-41. [Content Brief]
[2]. Nuijten M, et al. Cost Effectiveness of Paricalcitol versus a Non-Selective Vitamin D Receptor Activator for Secondary Hyperparathyroidism in the UK. Clin Drug Investig. 2010;30(8):545-57. [Content Brief]
[3]. Shiraishi A, et al. The advantage of alfacalcidol over vitamin D in the treatment of osteoporosis. Calcif Tissue Int. 1999 Oct;65(4):311-6. [Content Brief]
[4]. Nagaoka H, et al. Alfacalcidol enhances collagen quality in ovariectomized rat bones. J Orthop Res. 2014 Aug;32(8):1030-6. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Alfacalcidol (Standard) Related Classifications
HY-10003R Related Classifications
Powered by Bioz